Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington's disease?

Neuropsychologia

Volumn 45, Issue 13, 2007, Pages 2922-2930

  Beste, Christian ^a,b   Saft, Carsten ^a   Yordanova, Juliana ^c   Andrich, Jürgen ^a   Gold, Ralf ^a   Falkenstein, Michael ^b   Kolev, Vasil ^c  

^a St Josef Hospital   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Error negativity (Ne ERN); Event related potential (ERP); Flanker task; Huntington's disease; Performance monitoring; Time frequency decomposition

Indexed keywords

ADENOSINE RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BASAL GANGLION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; PATHOGENESIS;

ADAPTATION, PSYCHOLOGICAL; ADULT; AROUSAL; ATTENTION; CASE-CONTROL STUDIES; CEREBRAL CORTEX; COGNITION; EARLY DIAGNOSIS; EVOKED POTENTIALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; RECEPTORS, PURINERGIC P1; REFERENCE VALUES;

EID: 34548492007     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2007.06.004     Document Type: Article

References (59)

1. Augood S.J., Faull R.L., and Emson P.C. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Annals of Neurology 42 (1997) 215-221
2. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Shpritz B.D., et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63 (2004) 66-72
3. Backman L., Robins-Wahlin T.B., Lundin A., Ginovart N., and Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120 (1997) 2207-2217
4. Beal M.F., and Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nature Reviews Neuroscience 5 (2004) 373-384
5. Beste C., Saft C., Andrich J., Gold R., and Falkenstein M. Error processing in Huntington's disease. PloS One (2006) e86
6. Beste, C., Saft, C., Konrad, C., Andrich, J., Habbel, A., Schepers, I., et al. (2007). Levels of error processing in Huntington's disease: A combined study using event-related potentials and voxel-based morphometry. Human Brain Mapping. [Epub ahead of print.]
7. Bezard E., Gross C.E., and Brotchie J.M. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends in Neurosciences 26 (2003) 215-221
8. Bezard E., and Gross C.E. Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach. Progress in Neurobiology 55 (1998) 93-116
9. Blum D., Hourez R., Galas M.C., Popoli P., and Schiffmann S.N. Adenosine receptors and Huntington's disease: Implications for pathogenesis and therapeutics. Lancet Neurology 2 (2003) 366-374
10. Blum D., Galas M.C., Pintor A., Brouillet E., Ledent C., Muller C.E., et al. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: Implications for the neuroprotective potential of A2A antagonists. Journal of Neuroscience 23 (2003) 5361-5369
11. Carter C.S., Braver T.S., Barch D.M., Botvinivk M.M., Noll D., and Cohen J.D. Anterior cingulated cortex, error detection, and the online monitoring of performance. Science 280 (1998) 747-749
12. Clarke G., Collins R.A., Leavitt B.R., Andrews D.F., Hayden M.R., Lumsden C.J., et al. A one-hit model of cell death in inherited neuronal degenerations. Nature 406 (2000) 195-199
13. Craufurd D., and Snowden J. Neuropsychological and neuropsychiatric aspects of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease. 3rd ed. (2002), Oxford University Press, Oxford, UK 62-95
14. de Bruijn E.R., Sabbe B.G., Hulstjin W., Ruigt G.S., and Verkes R.J. Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers. Brain Research 1105 (2006) 122-129
15. Falkenstein M., Hielscher H., Dziobek I., Schwarzenau P., Hoormann J., Sunderman B., et al. Action monitoring, error detection, and the basal ganglia: An ERP study. Neuroreport 22 (2001) 157-161
16. Falkenstein M., Hoormann J., Christ S., and Hohnsbein J. ERP components on reaction errors and their functional significance: A tutorial. Biological Psychology 51 (2000) 87-107
17. Falkenstein M., Hohnsbein J., Hoormann J., and Blanke L. Effects of crossmodal divided attention on the ERP components, II. Error processing in choice reaction tasks. Electroencephalography Clinical Neurophysiology 78 (1991) 447-455
18. Feigin A., Ghilardi M.F., Huang C., Ma Y., Carbon M., Guttman M., et al. Preclinical Huntington's disease: Compensatory brain responses during learning. Annals of Neurology 59 (2006) 53-59
19. Filip M., Frankowska M., Zaniewska M., Przegalinski E., Muller C.E., Agnati L., et al. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine. Brain Research 1077 (2006) 67-80
20. Fuxe K., Ferre S., Canals M., Torvinen M., Terasmaa A., Marcellino D., et al. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. Journal of Molecular Neuroscience 26 (2005) 209-220
21. Gehring W.J., and Knight R.T. Prefrontal-cingulate interactions in action monitoring. Nature Neuroscience 3 (2000) 516-520
22. Gehring W.J., Goss B., Coles M.G.H., Meyer D.E., and Donchin E. A neural system for error detection and compensation. Psychological Sciences 4 (1993) 385-390
23. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Swahn C.G., et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegeneration process in Huntington's disease. Brain 120 (1997) 503-514
24. Gratton G., Coles M.G., and Donchin E. A new method for off-line removal of ocular artefact. Electroencephalography Clinical Neurophysiology 55 (1983) 468-484
25. Gutekunst C.A., Norflus F., and Hersch S.M. The neuropathology of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease. 3rd ed. (2002), Oxford University Press, Oxford, UK 251-276
26. Holroyd C.B., and Yeung N. Alcohol and error processing. Trends in Neuroscience 26 (2003) 402-404
27. Holroyd C.B., and Coles M.G. The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity. Psychology Reviews 109 (2002) 679-709
28. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntingtońs disease chromosomes. Cell 72 (1993) 971-983
29. Jarabek B.R., Yasuda R.P., and Wolfe B.B. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in Huntington's mouse model. Brain 127 (2004) 505-516
30. Jensen O., Hari R., and Kaila K. Visually evoked gamma responses in the human brain are enhanced during voluntary hyperventilation. Neuroimage 15 (2002) 575-586
31. Kassubek J., Bernhard Landwehrmeyer G., Ecker D., Juengling F.D., Schuller S., Weindl A., et al. Global cerebral atrophy in early stages of Huntington's disease: Quantitative MRI study. Neuroreport 15 (2004) 363-365
32. Kopp B., Rist F., and Mattler U. N200 in the flanker task as a neurobehavioral tool for investigating executive control. Psychophysiology 33 (1996) 282-294
33. Maglione V., Giallonardo P., Cannella M., Martino T., Frati L., and Squitieri F. Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 139 (2005) 101-105
34. Miller J., Patterson T., and Ulrich R. Jackknife-based method for measuring LRP onset latency. Psychophysiology 35 (1998) 99-115
35. Nunez P.L., Srinivasan R., Westdorp A.F., Wijesinghe R.S., Tucker D.M., Silberstein R.B., et al. EEG coherency. I: Statistics, reference electrode, volume conduction, Laplacians, cortical imaging, and interpretation at multiple scales. Electroencephalography Clinical Neurophysiology 103 (1997) 499-515
36. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin .L., et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR American Journal of Neuroradiology 25 (2004) 1715-1721
37. Paulsen J.S., Zhao H., Stout J.C., Brinkman R.R., Guttman M., Ross C.A., et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 57 (2001) 658-662
38. Perrin F., Pernier J., Bertrand O., and Echallier J.F. Spherical splines for scalp potential and current density mapping. Eletroencephalography Clinical Neurophysiology 72 (1989) 184-187
39. Peruz M.F., and Windle A.H. Cause of neuronal death in neurodegenerative disease attributable to expansion of glutamine repeats. Nature 412 (2001) 143-144
40. Ranen N.G., Stine O.C., Abbott M.H., Sherr M., Codori A.M., Franz M.L., et al. Anticipation and instability if IT-15 (CAG)n repeats in parent-offspring pairs with Huntington's disease. American Journal of Human Genetics 57 (1995) 593-602
41. Ridderinkhof K.R., Ullsperger M., Crone E.A., and Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 306 (2004) 443-447
42. Ridderinkhof K.R., de Vlugt Y., Bramlage A., Spaan M., Elton M., Snel J., et al. Alcohol consumption impairs detection of performance errors in mediofrontal cortex. Science 298 (2002) 2209-2211
43. Rosas H.D., Feigin A.S., and Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 1 (2004) 263-272
44. Samar V.J., Bopardikar A., Rao R., and Swartz K. Wavelet analysis of neuroelectric waveforms: A conceptual tutorial. Brain and Language 66 (1999) 7-60
45. Short J.L., Ledent C., Borrelli E., Drago J., and Lawrence A.J. Genetic interdependence of adenosine and dopamine receptors: Evidence from receptor knockout mice. Neuroscience 139 (2006) 661-670
46. Smith M.A., Brandt J., and Shadmehr R. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403 (2000) 544-549
47. Stahl J., and Gibbons H. The application of jackknife-based onset detection of lateralized readiness potential in correlative approaches. Psychophysiology 41 (2004) 845-860
48. Svenningsson P., Le Moine C., Fisone G., and Fredholm B.B. Distribution, biochemistry and function of striatal adenosine A2A receptors. Progress in Neurobiology 59 (1999) 355-396
49. Tallon-Baudry C., Bertrand O., Delpuech C., and Permier J. Oscillatory gamma-band (30-70 Hz) activity induced by a visual search task in humans. Journal of Neuroscience 17 (1997) 722-734
50. Tarditi A., Cimurri A., Varani K., Borea P.A., Woodman B., Bates G., et al. Early and transient alteration of adenosine A2A receptor signalling in a mouse model of Huntington's disease. Neurobiology of Disease 23 (2006) 44-53
51. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125 (2002) 1815-1828
52. Turjanski N., Weeks R., Dolan R., Harding A.E., and Brooks D.J. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Brain 118 (1995) 689-696
53. Ulrich R., and Miller J. Using the jackknife-based scoring method for measuring LRP onset effects in factorial designs. Psychophysiology 38 (2001) 816-827
54. Van Oostrom J.C., Maquire R.P., Verschuuren-Bememans C.C., Veenma-van der Duin L., Pruim J., Roos R.A., et al. Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology 6 (2005) 941-943
55. Voermans N.C., Petersson K.M., Daudey L., Weber B., Van Spaendonck K.P., Kremer H.P., et al. Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 43 (2004) 427-435
56. Yohrling IV G.J., and Cha J.H.J. Neurochemistry of Huntington 's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease. 3rd ed. (2002), Oxford University Press, Oxford, UK 276-309
57. Yordanova J., Falkenstein M., Hohnsbein J., and Kolev V. Parallel systems of error processing in the brain. Neuroimage 22 (2004) 590-602
58. Yordanova J., Kolev V., Hohnsbein J., and Falkenstein M. Sensorimotor slowing with ageing is mediated by a functional dysregulation of motor-generation processes: Evidence from high-resolution event-related potentials. Brain 127 (2004) 351-362
59. Zirnheld P.J., Carroll C.A., Kieffaber P.D., ÓDonnell B.F., Shekar A., and Hetrick W.P. Haloperidol impairs learning and error-related negativity in humans. Journal of Cognitive Neuroscience 16 (2004) 1098-1112